The herd has given up on gold.

But you shouldn't follow the herd. Because if you do, you could miss out on gold's next massive move higher.

As a refresher, gold and other precious metals became popular trades back in 2025 and early 2026. Central banks were buying these resources at record rates, and speculators soon sent prices soaring.

Gold peaked at nearly $5,420 an ounce in late January of this year. Then it came crashing down.

As of yesterday's close, gold is down 24% from its peak.

And as you can see below, gold funds just saw their fourth consecutive week of outflows...

With AI stocks soaring, no one cares about gold anymore. But this is a big mistake.

Gold has the potential to skyrocket from here. I believe it can easily hit $7,000 an ounce – or even higher. There are a few reasons I'm so bullish today...

First, central banks continue to be massive buyers of gold.

They bought a net 244 tonnes of gold in the first quarter of this year. That's a 3% increase from a year ago...

Next, gold bull markets tend to last far longer than most folks expect.

Gold is only up about 150% since 2022. Going back further, it's up 280% since 2015.

That's nothing compared with history's great bull markets. For example, from 1976 to 1980, gold surged 549%. And from 2001 to 2011, it rose 636%.

The metal still has a long way to go if it's going to catch up to those bull markets.

More generally, gold is the ultimate "chaos hedge." It's a store of value even in turbulent times. And investors will have plenty of reasons to seek safety in the months to come given how much speculation there is with AI and tech stocks.

Also, this year's edition of the annual "In Gold We Trust" report, published by asset manager Incrementum, notes that gold is currently in a "consolidation phase" after a terrific run in 2025. In other words, the metal's price is stabilizing before it breaks either higher or lower. As the report explains...

Following gold's spectacular rally of the preceding quarters, a consolidation phase was not only likely but, from a technical perspective, overdue. The impetus came from the very event that, by the textbook, should have had the opposite effect: the Iran crisis. While a large portion of market participants speculated on another price jump, the market swung in the opposite direction – the war did not become a catalyst but rather the trigger for a healthy correction. No upward trend is linear; even structural bull markets require phases of correction, position adjustment, and sentiment unwinding.

The report continues...

As expected, the mainstream declared the safe-haven a failure. But those who understand the mechanism recognize a familiar pattern: During periods of acute financial stress, gold is sold not in spite of, but because of its high liquidity. We saw exactly the same pattern in October 2008, with a 29% drop, when the Lehman [Brothers] bankruptcy triggered margin calls across all asset classes, and in March 2020, when a wave of liquidation swept through the market in the early stages of the Covid-19 pandemic and gold fell by 12%.

However, following both those periods of financial stress, gold went on to rebound in a hurry. And it looks like the precious metal is following a similar trajectory today.

Take a look...

If history rhymes with the late 2000s and early 2020s, gold could have a lot more room to run from here.

Finally, a big reason I'm bullish on the yellow metal today is because of a narrative most investors are unaware of...

It has to do with the U.S. Treasury potentially "revaluing" gold. That one simple move would send the metal screaming higher. And those who are unprepared could lose up to 40% of their wealth overnight.

I put together a presentation that explains the whole story and tells you the best way to profit with my No. 1 gold stock...

You could multiply your money 5 to 10 times in the next few years with this name. In fact, when my firm recommended this exact same stock publicly in the past, real people like you saw gains as high as 995%.

Click here to get the full story.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
June 24, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top